Page 69 - 2022-36-中国全科医学
P. 69

·4544· http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn


           [9]MA  K,JIN  Y,WANG  L,et  al.  Intrathecal  delivery  of   (2019 年 版)[J].  中 国 肿 瘤 临 床,2019,46(6):267-
               hydromorphone  vs  morphine  for  refractory  cancer  pain:a   271. DOI:10.3969/j.issn.1000-8179.2019.06.228.
               multicenter,randomized,single-blind,controlled noninferiority   [20]路桃影,李艳,夏萍,等 . 匹兹堡睡眠质量指数的信度及效
               trial[J]. Pain,2020,161(11):2502-2510. DOI:10.1097/j.  度 分 析[J].  重 庆 医 学,2014,43(3):260-263. DOI:
               pain.0000000000001957.                               10.3969/j.issn.1671-8348.2014.03.002.
           [10]WAN C F,MENG Q Z,WANG Y W,et al. Patient-controlled   LU T Y,LI Y,XIA P,et al. Analysis on reliability and validity
               subcutaneous analgesia using sufentainil or morphine in home care   of the Pittsburgh sleep quality index[J]. Chongqing Medicine,
               treatment in patients with stage Ⅲ - Ⅳ cancer:a multi-center   2014,43(3):260-263.  DOI:10.3969/j.issn.1671-
               randomized controlled clinical trial[J]. Cancer Med,2020,9(15):  8348.2014.03.002.
               5345-5352. DOI:10.1002/cam4.3194.               [21]AARONSON N K,AHMEDZAI S,BERGMAN B,et al. The
           [11]NIE Z B,LI Z H,LU B,et al. Hydromorphone vs sufentanil in   European Organization for Research and Treatment of Cancer
               patient-controlled analgesia for postoperative pain management:a   QLQ-C30:a quality-of-life instrument for use in international
               meta-analysis[J]. Medicine (Baltimore),2022,101(3):  clinical trials in oncology[J]. J Natl Cancer Inst,1993,85(5):
               e28615. DOI:10.1097/MD.0000000000028615.             365-376. DOI:10.1093/jnci/85.5.365.
           [12]YAN G M,CHEN J,YANG G Y,et al. Effects of patient-  [22]HENSON L A,MADDOCKS M,EVANS C,et al. Palliative care
               controlled  analgesia  with  hydromorphone  or  sufentanil  on   and the management of common distressing symptoms in advanced
               postoperative pulmonary complications in patients undergoing   cancer:pain,breathlessness,nausea  and  vomiting,and
               thoracic  surgery:a  quasi-experimental  study[J].  BMC   fatigue[J]. J Clin Oncol,2020,38(9):905-914. DOI:
               Anesthesiol,2018,18(1):192. DOI:10.1186/s12871-018-  10.1200/JCO.19.00470.
               0657-7.                                         [23]谢广伦,陈昊 .  疼痛治疗时机和方法对癌症治疗结局的影
           [13]蒋奇明,戴萍,顾云峰,等 . 氢吗啡酮与舒芬太尼在下肢骨折                        响[J]. 中华医学杂志,2020,100(17):1350-1353. DOI:
               术后硬膜外自控镇痛中的效果比较[J]. 四川医学,2019,                       10.3760/cma.j.cn112137-20191221-02789.
               40(3):295-298. DOI:10.16252/j.cnki.issn1004-0501-  [24]MERCADANTE S. Options for treating pain in cancer patients
               2019.03.020.                                         with dysphagia[J]. Drugs,2017,77(6):629-635. DOI:
               JIANG Q M,DAI P,GU Y F,et al. Comparison of the efficacy   10.1007/s40265-017-0710-8.
               of hydromorphone and sufentanil in PCEA after lower limb fracture   [25]LIN R B,LIN S Z,FENG S T,et al. Comparing patient-controlled
               surgery[J]. Sichuan Medical Journal,2019,40(3):295-  analgesia versus non-PCA hydromorphone titration for severe cancer
               298. DOI:10.16252/j.cnki.issn1004-0501-2019.03.020.  pain:a randomized phase Ⅲ trial[J]. J Natl Compr Canc Netw,
           [14]YANG Y Q,WU J P,LI H L,et al. Prospective investigation   2021:1-8. DOI:10.6004/jnccn.2020.7699.
               of intravenous patient-controlled analgesia with hydromorphone   [26]NIJLAND L,SCHMIDT P,FROSCH M,et al. Subcutaneous or
               or sufentanil:impact on mood,opioid adverse effects,and   intravenous opioid administration by patient-controlled analgesia
               recovery[J]. BMC Anesthesiol,2018,18(1):37. DOI:     in cancer pain:a systematic literature review[J]. Support Care
               10.1186/s12871-018-0500-1.                           Cancer,2019,27(1):33-42. DOI:10.1007/s00520-018-
           [15]王昆,金毅 . 难治性癌痛专家共识(2017 年版)[J]. 中国肿                   4368-x.
               瘤临床,2017,44(16):787-793.                        [27]郑碧鑫,宋莉,刘慧 . 氢吗啡酮用于癌性疼痛治疗的研究进
           [16]AZAM F,LATIF M F,FAROOQ A,et al. Performance status   展[J]. 中国疼痛医学杂志,2018,24(9):649-652. DOI:
               assessment by using ECOG(Eastern Cooperative Oncology Group)  10.3969/j.issn.1006-9852.2018.09.002.
               score for cancer patients by oncology healthcare professionals[J].   [28]FELDEN L,WALTER C,HARDER S,et al. Comparative clinical
               Case  Rep  Oncol,2019,12(3):728-736.  DOI:           effects of hydromorphone and morphine:a meta-analysis[J]. Br J
               10.1159/000503095.                                   Anaesth,2011,107(3):319-328. DOI:10.1093/bja/aer232.
           [17]BRIERLEY J D,GOSPODAROWICZ M K,WITTEKIND C. 恶性  [29]OH S K,LEE I O,LIM B G,et al. Comparison of the analgesic
               肿瘤 TNM 分期(第 8 版)[M]. 王平,梁寒,译 . 天津:天                  effect of sufentanil versus fentanyl in intravenous patient-controlled
               津科技翻译出版公司,2019.                                      analgesia after total laparoscopic hysterectomy:a randomized,
           [18]KIM H J,JUNG S O. Comparative evaluations of single-item pain-  double-blind,prospective study[J]. Int J Med Sci,2019,16(11):
               intensity measures in cancer patients:numeric rating scale vs.   1439-1446. DOI:10.7150/ijms.34656.
               verbal rating scale[J]. J Clin Nurs,2020,29(15/16):2945-  [30]肖燕 .  舒芬太尼自控式镇痛泵在重度癌痛患者中的应用进
               2952. DOI:10.1111/jocn.15341.                        展[J]. 江西医药,2019,54(7):871-874. DOI:10.3969/j.
           [19]中国抗癌协会癌症康复与姑息治疗专业委员会难治性癌痛学                           issn.1006-2238.2019.7.056.
               组,中华医学会疼痛学分会癌痛学组 . 癌性爆发痛专家共识                    [31]李小梅,肖文华,焦顺昌,等 . 一项癌痛患者焦虑抑郁的回顾
   64   65   66   67   68   69   70   71   72   73   74